Bicycle Therapeutics (BCYC) EBT Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,688.00 |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | -621,816.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -621,816.00 |
| Dec 31, 2025 | -346,949.00 |
| Sep 30, 2025 | 152,536.00 |
| Jun 30, 2025 | -228,768.00 |
| Mar 31, 2025 | -36,106.00 |
| Dec 31, 2024 | 440,202.00 |
| Sep 30, 2024 | -113,741.00 |
| Jun 30, 2024 | -4,572.00 |
| Mar 31, 2024 | 55,172.00 |
| Dec 31, 2023 | -59,969.00 |
| Sep 30, 2023 | 5,042.00 |
| Jun 30, 2023 | -5,364.00 |
| Mar 31, 2023 | -8,555.00 |
| Dec 31, 2022 | 78,797.00 |
| Sep 30, 2022 | -59,197.00 |
| Jun 30, 2022 | 68,779.00 |
| Mar 31, 2022 | 18,938.00 |
| Dec 31, 2021 | -71,959.00 |
| Sep 30, 2021 | -7,235.00 |
| Jun 30, 2021 | -23,515.00 |
| Mar 31, 2021 | 9,816.00 |
| Dec 31, 2020 | -36,843.00 |
| Sep 30, 2020 | 132,223.00 |
| Jun 30, 2020 | -11,492.00 |
| Mar 31, 2020 | -91,188.00 |
| Dec 31, 2019 | 54,224.00 |
| Sep 30, 2019 | -112,044.00 |
| Jun 30, 2019 | -36,266.00 |
| Mar 31, 2019 | 373.00 |